GSK3B and hepatocellular carcinoma: A recent study described that miR-96 was up-regulated in HCC tissues and HepG2 cells, miR-96 inhibiting FoxO1 and thus activating the AKT/GSK-3β/β-catenin signaling pathway, exerted its carcinogenic effect (60).